The benefits of clustering in TNF receptor superfamily signaling

The benefits of clustering in TNF receptor superfamily signaling

The tumor necrosis factor (TNF) receptor superfamily is a structurally and functionally related group of cell surface receptors that play crucial roles in various cellular processes, including apoptosis, cell survival, and immune regulation. This review paper synthesizes key findings from recent stu...

Bibliografiset tiedot
Päätekijät:	Éva S. Vanamee, Denise L. Faustman
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Frontiers Media S.A. 2023-08-01
Sarja:	Frontiers in Immunology
Aiheet:	TNF receptor superfamily (TNFRSF) TNF signaling receptor clustering TNFR agonism and antagonism signal amplification
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1225704/full

Samankaltaisia teoksia

Signal Amplification in Highly Ordered Networks Is Driven by Geometry
Tekijä: Éva S. Vanamee, et al.
Julkaistu: (2022-01-01)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
Tekijä: Kirstin Kucka, et al.
Julkaistu: (2021-02-01)

Editorial: TNFR Superfamily Oligomerization and Signaling
Tekijä: Olivier Micheau, et al.
Julkaistu: (2021-04-01)

TNF RECEPTOR 2 AND DISEASE: Autoimmunity and Regenerative Medicine
Tekijä: Denise Louise Faustman, et al.
Julkaistu: (2013-12-01)

Regulation of Tissue Responses: The TWEAK/Fn14 Pathway and other TNF/ TNFR Superfamily Members that Can Signal through noncanonical NFkB
Tekijä: Linda C Burkly
Julkaistu: (2015-03-01)

Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists
Tekijä: George Fromm, et al.
Julkaistu: (2023-09-01)

The Roles of TNF Signaling Pathways in Metabolism of Bone Tumors
Tekijä: Haiying Zhou, et al.
Julkaistu: (2022-06-01)

On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function
Tekijä: Éva S. Vanamee, et al.
Julkaistu: (2020-03-01)

TNF superfamily control of tissue remodeling and fibrosis
Tekijä: Hope Steele, et al.
Julkaistu: (2023-07-01)

Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation
Tekijä: Vu Thuy Khanh Le-Trilling, et al.
Julkaistu: (2023-08-01)

Receptor Specificity Engineering of TNF Superfamily Ligands
Tekijä: Fengzhi Suo, et al.
Julkaistu: (2022-01-01)

Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy
Tekijä: Silvia Piantoni, et al.
Julkaistu: (2021-05-01)

The role of the TNF receptors and apoptosis inducing ligands in tumor growth
Tekijä: O. H. Minchenko1, et al.
Julkaistu: (2016-10-01)

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2)
Tekijä: Ehsan Ghamari, et al.
Julkaistu: (2016-01-01)

TNFR1 Absence Is Not Crucial for Different Types of Cell Reaction to TNF: A Study of the TNFR1-Knockout Cell Model
Tekijä: Alina A. Alshevskaya, et al.
Julkaistu: (2024-04-01)

Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
Tekijä: Federica Azzolini, et al.
Julkaistu: (2023-05-01)

Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
Tekijä: Isela Martínez-Reza, et al.
Julkaistu: (2017-12-01)

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Tekijä: Roman Fischer, et al.
Julkaistu: (2020-05-01)

Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future
Tekijä: Hongtao Zhang, et al.
Julkaistu: (2021-01-01)

Bilateral muscle fiber and nerve influences by TNF-alpha in response to unilateral muscle overuse – studies on TNF receptor expressions
Tekijä: Lina Renström, et al.
Julkaistu: (2017-11-01)

Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Tekijä: Ayaka Sato, et al.
Julkaistu: (2025-01-01)

TRAF1 Signaling in Human Health and Disease
Tekijä: Maria I. Edilova, et al.
Julkaistu: (2018-12-01)

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors
Tekijä: Gururaj Shivange, et al.
Julkaistu: (2021-11-01)

Extracellular Vesicles from Hyperammonemic Rats Induce Neuroinflammation and Motor Incoordination in Control Rats
Tekijä: Paula Izquierdo-Altarejos, et al.
Julkaistu: (2020-02-01)

Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors
Tekijä: Cindy A. Sander, et al.
Julkaistu: (2022-07-01)

Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
Tekijä: Nicholas Frazzette, et al.
Julkaistu: (2022-06-01)

Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Tekijä: Portia Gough, et al.
Julkaistu: (2020-11-01)

Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders
Tekijä: Yun Dong, et al.
Julkaistu: (2015-11-01)

Re-Examining the Role of TNF in MS Pathogenesis and Therapy
Tekijä: Diego Fresegna, et al.
Julkaistu: (2020-10-01)

Leveraging the tolerogenic potential of TNF-α and regulatory B cells in organ transplantation
Tekijä: Sonya A. Poznansky, et al.
Julkaistu: (2023-04-01)

Novel anti-atrophic peptide isolated from olive flounder surimi as a nutraceutical additive against TNF-α induced muscle atrophy
Tekijä: N.M. Liyanage, et al.
Julkaistu: (2023-11-01)

Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
Tekijä: Yadira Palacios, et al.
Julkaistu: (2022-05-01)

Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
Tekijä: Huimin Zou, et al.
Julkaistu: (2018-03-01)

Reverse Signaling Contributes to Control of Chronic Inflammation by Anti-TNF Therapeutics
Tekijä: Orsolya Sipos, et al.
Julkaistu: (2015-06-01)

Association of TNFRSF19 with a TNF family-based prognostic model and subtypes in gliomas using machine learning
Tekijä: Youwei Guo, et al.
Julkaistu: (2024-04-01)

Anti-TNF-α Compounds as a Treatment for Depression
Tekijä: Sarit Uzzan, et al.
Julkaistu: (2021-04-01)

Concomitant Retinal Alterations in Neuronal Activity and TNFα Pathway Are Detectable during the Pre-Symptomatic Stage in a Mouse Model of Alzheimer’s Disease
Tekijä: Virginie Dinet, et al.
Julkaistu: (2022-05-01)

Consequences of the Lack of TNFR1 in Ouabain Response in the Hippocampus of C57BL/6J Mice
Tekijä: Paula Fernanda Kinoshita, et al.
Julkaistu: (2022-11-01)

The evolution of TNF signaling in platyhelminths suggests the cooptation of TNF receptor in the host-parasite interplay
Tekijä: Claudio R. Bertevello, et al.
Julkaistu: (2020-09-01)

Eosinophil recruitment in TNF-receptor-deficient mice
Tekijä: Shepherd Malcolm, et al.
Julkaistu: (2001-06-01)